TD Cowen Initiates a Buy Rating on RAPT Therapeutics (RAPT)
I'm PortAI, I can summarize articles.
TD Cowen analyst Yaron Werber initiated a Buy rating on RAPT Therapeutics with a price target of $64.38. Werber, known for his strong track record in the Healthcare sector, has an average return of 24.4% and a 59.88% success rate on recommended stocks. RAPT Therapeutics holds a consensus Strong Buy rating among analysts.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments